Last checked at 15 Jun 2021 07:51
LONDON MARKET PRE-OPEN: AstraZeneca jab effective against Delta strain
LONDON MARKET PRE-OPEN: AstraZeneca jab effective against Delta strain
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Astrazeneca Share News (AZN)
AZN Share
Price
AZN Share
News2
AZN Share
Chat
AZN Share
Trades18,685
AZN
Live RNS
AZN Share
Charts
AZN Level 2
Console
AZN Live
Share Price
AZN Broker
Ratings
AZN Directors
Deals
AZN Financial
Diary
AZN
Fundamentals
AZN Short
Positions
AZN
Media
Astrazeneca Information
Share Price Information for Astrazeneca (AZN)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
11,352.00
Bid:
11,348.00
Ask:
11,350.00
Change:
84.00 (0.75%)
Spread:
2.00 (0.018%)
Open:
11,288.00
High:
11,412.00
Low:
11,288.00
Prev. Close:
11,268.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.15 Jun 2021 07:45
AstraZeneca antibody fails to prevent Covid in exposed patients
(Sharecast News) - AstraZeneca said a study of its monoclonal antibody treatment, AZD7442, did not meet the main goal of preventing symptomatic Covid-19 in people exposed to the coronavirus in the past eight days.
Read more15 Jun 2021 07:27
UPDATE 4-AstraZeneca antibody cocktail fails to prevent COVID-19 in large trial
* No reliable results from trial to show prevention of infections* AstraZeneca has five more ongoing trials* Industry testing range of antibodies (Updates regulatory review of rivals)By Vishwadha Chander and Ludwig BurgerJune 15 (Reuters) - AstraZe...
Read more15 Jun 2021 07:27
UPDATE 3-Astra antibody cocktail failsĀ to prevent COVID-19 symptoms in large trial
* No reliable results from trial to show prevention of infections* AstraZeneca has five more ongoing trials* Industry testing range of antibodies (Recasts, adds details of antibody therapy, U.S. deal, analyst quote)By Vishwadha Chander and Ludwig ...
Read more14 Jun 2021 20:14
COVID SCIENCE-Delta variant doubles risk of hospitalization; Novavax vaccine highly effective in large trial
By Nancy LapidJune 14 (Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.Delta variant doubles risk of ...
Read more14 Jun 2021 18:00
UK study finds vaccines offer high protection against hospitalisation from Delta variant
LONDON, June 14 (Reuters) - COVID-19 vaccines made by Pfizer and AstraZeneca offer high protection of more than 90% against hospitalisation from the Delta coronavirus variant, a new analysis by Public Health England (PHE) showed on Monday.Prime M...
Read more14 Jun 2021 15:00
CORRECTED-Delta variant doubles risk of COVID hospitalisation - Scottish study
(Corrects typographical error in paragraph 4 to show number hospitalised with Delta variant was 134, not 1234)LONDON, June 14 (Reuters) - The Delta coronavirus variant doubles the risk of hospitalisation compared with the previously dominant varia...
Read more14 Jun 2021 15:00
Delta variant doubles risk of COVID hospitalisation - Scottish study
LONDON, June 14 (Reuters) - The Delta coronavirus variant doubles the risk of hospitalisation compared with the previously dominant variant in Britain, but two doses of vaccine still provide strong protection, a Scottish study found on Monday.The ...
Read more13 Jun 2021 20:18
EMA official says AstraZeneca shots have good risk-benefit profile for over 60s
MILAN, June 13 (Reuters) - The head of the EU drug regulator's COVID-19 task force said on Sunday that AstraZeneca's coronavirus vaccine had a favourable risk-benefit profile for all age groups and particularly for those aged over 60.Italian news...
Read more13 Jun 2021 15:04
'No fear' decision to limit AstraZeneca can hamper COVID-19 vaccinations-Italy PM
CARBIS BAY, England, June 13 (Reuters) - There is "no fear" that a decision not to use AstraZeneca COVID-19 shots on people aged under 60 will hamper the Italian vaccination campaign, Prime Minister Mario Draghi said on Sunday."The vaccination pla...
Read more11 Jun 2021 22:30
Oxford vaccine inventors recognised in Queen's Birthday Honours
LONDON, June 11 (Reuters) - The Oxford University scientists who invented the AstraZeneca COVID-19 vaccine are among those to be honoured by Queen Elizabeth, among a number of recipients who played key roles in Britain's coronavirus response, the ...
Read more11 Jun 2021 18:05
UPDATE 1-Italy halts AstraZeneca vaccine for under-60s
(Adds details, background)By Gavin JonesROME, June 11 (Reuters) - The Italian government said on Friday it was restricting the use of the AstraZeneca COVID-19 vaccine to people over the age of 60, after a teenager who had received the shot died fr...
Read more11 Jun 2021 16:11
Italy halts AstraZeneca vaccine for under-60s after teenager dies
ROME, June 11 (Reuters) - The Italian government said on Friday it was restricting the use of the AstraZeneca COVID-19 vaccine to people over the age of 60, after a teenager who had taken the shot died from a blood clot.Camilla Canepa died on Thur...
Read more11 Jun 2021 14:22
EU advises against Astra vaccine for people with blood vessel syndrome
EU advises against Astra vaccine for people with blood vessel syndrome
Read more11 Jun 2021 14:20
UK medicine regulator looking at capillary leak syndrome precaution for AstraZeneca shot
LONDON, June 11 (Reuters) - Britain's MHRA medicine regulator is considering precautionary advice for people with a history of capillary leak syndrome but does not see a causal link with AstraZeneca's COVID-19 vaccine after the EU said it was a r...
Read more